The round was led by Healthcare Venture Partners, bringing the total raised to over $36M. MyOme plans to use the funds to begin commercialization of their clinical whole genome analysis platform technology and clinical reports to health systems. The MyOme platform will help families understand and manage their risk for inherited disease.

MyOme is a clinical whole genome analysis platform company helping families understand their risk for inherited diseases. MyOme leverages the power of the whole genome for a lifetime of actionable insights. Certified under the Clinical Laboratory Improvement Amendments (CLIA), MyOme is based in Menlo Park, California.